Lionel Carnot
Lionel Carnot has made 56 investments in companies such as: Dermira, Phenomix, NuPathe, Cydan, TRIA Beauty, SynGen, Vivaldi Biosciences, PTC Therapeutics, Sunesis Pharmaceuticals, Epizyme, Hyperion Therapeutics, Avera Pharmaceutical, Oculis, Altheos, Ascendancy, VIA Pharmaceuticals, Xeris Pharmaceuticals, BrainCells, Imara, Aragon Surgical, Oculex Pharmaceuticals, Reliant Pharmaceuticals, CymaBay Therapeutics, NextWave Pharmaceuticals, Nevro, NextCure, IDEV Technologies, Accriva Diagnostics, Interleukin Genetics, Epocrates, Aviir, Pharmion, Aciex Therapeutics, Nabsys, Ion Torrent, Civitas Therapeutics, Fabric Genomics (formerly Omicia), Xilio Therapeutics, Vtesse, Radiant Medical, EnteroMedics, Cadence Pharmaceuticals, Conatus Pharmaceuticals, Gossamer Bio, Calypso Medical, VYNE Therapeutics, KBP Biosciences, Merus, Presidio Pharmaceuticals, Gritstone Oncology, NBI Development, PharmAkea Therapeutics, Twist Bioscience, Kezar Life Sciences, Iterum Therapeutics, MAP Pharmaceuticals.
Location of Lionel Carnot is Zug, Switzerland.The free version of Angel Match provides limited data for Lionel Carnot. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.
Lionel Carnot is a Managing Director and he his investment types are: Venture Capital.Lionel Carnot focuses investing in industries such as: Biotechnology, Health Care, Pharmaceutical, Health Diagnostics, Therapeutics, Biopharma, Genetics, Women Founded, Women Led, Life Science.A short brief about investor: